| 发明名称 |
COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A MDM2 INHIBITOR |
| 摘要 |
The present invention is directed to the combination therapy of an afucosylated anti-CD20 antibody with a MDM2 inhibitor for the treatment of cancer, especially to the combination therapy of CD20 expressing cancers with an afucosylated humanized B-Ly1 antibody and a MDM2 inhibitor. |
| 申请公布号 |
US2014140988(A1) |
申请公布日期 |
2014.05.22 |
| 申请号 |
US201313917327 |
申请日期 |
2013.06.13 |
| 申请人 |
ROCHE GLYCART AG |
发明人 |
ELDERING ERIC;HERTING FRANK;KLEIN CHRISTIAN;VAN OERS MARINUS H.J. |
| 分类号 |
A61K39/395;A61K31/4545;A61K31/496 |
主分类号 |
A61K39/395 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
